ArticleFrontiers in oncology2021

Loss of 5-Hydroxymethylcytosine as an Epigenetic Signature That Correlates With Poor Outcomes in Patients With Medulloblastoma.

Fu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.